ClinVar Miner

Submissions for variant NM_152296.5(ATP1A3):c.2267G>A (p.Arg756His) (rs606231435)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000489717 SCV000577376 pathogenic not provided 2017-12-20 criteria provided, single submitter clinical testing The R756H variant in the ATP1A3 gene has previously been reported in patients with ataxia, choreoathetosis, hypotonia, seizures, pectus excavatum, functional respiratory abnormality, and abnormalities of hair pigmentation and texture (Brashear et al., 2012; Fitzgerald et al., 2015). This variant has also been observed as a de novo finding in another individual testted at GeneDx with features of an ATP1A3-related disorder. The R756H variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although this variant is a conservative amino acid substitution, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in the same residue (R756C) has been reported in an individual with alternating hemiplegia of childhood (Kanemasa et al., 2016), supporting the functional importance of this residue of the protein. We interpret R756H as a pathogenic variant.
TIDEX, University of British Columbia RCV000148315 SCV000586841 pathogenic Dystonia 12 criteria provided, single submitter research
Invitae RCV000148315 SCV000645400 pathogenic Dystonia 12 2019-10-25 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 756 of the ATP1A3 protein (p.Arg756His). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several individuals and families affected with rapid onset dystonia-parkinsonism (PMID: 28441826, 22924536, 28500446) including one de novo observation (PMID: 24793181). It has also been observed to segregate with alternating hemiplegia in a family (PMID: 25996915). ClinVar contains an entry for this variant (Variation ID: 161134). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). A different missense substitution at this codon (p.Arg756Cys) has been determined to be pathogenic (PMID: 27634470, 26400718, 27268479, 29066118, 29397530, 27726050). This suggests that the arginine residue is critical for ATP1A3 protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.
Institute of Human Genetics,Klinikum rechts der Isar RCV000578251 SCV000680148 pathogenic Alternating hemiplegia of childhood 2 2017-09-08 criteria provided, single submitter clinical testing
Ambry Genetics RCV000624894 SCV000741248 likely pathogenic Inborn genetic diseases 2016-02-16 criteria provided, single submitter clinical testing
Undiagnosed Diseases Network,NIH RCV000791274 SCV000930561 pathogenic Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 2019-03-07 criteria provided, single submitter clinical testing
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV000578251 SCV000996218 pathogenic Alternating hemiplegia of childhood 2 2018-11-29 criteria provided, single submitter clinical testing This variant has been previously reported as a heterozygous change in multiple patients with neurological presentations consistent with an ATP1A3-related disorder (PMID: 22924536, 28382329, 28500446, 28647130). This variant is commonly referred to in the literature as p.Arg756His due to use of a different reference transcript (NM_152296). It has been reported as a likely pathogenic or pathogenic change by multiple clinical diagnostic laboratories in ClinVar (variant ID: 161134). The c.2306G>A (p.Arg769His) variant is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. It affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.2306G>A (p.Arg769His) variant is classified as pathogenic.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000489717 SCV001247066 pathogenic not provided 2016-11-01 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV000148315 SCV001428565 pathogenic Dystonia 12 2018-01-30 criteria provided, single submitter clinical testing
GeneReviews RCV000148315 SCV000195703 pathogenic Dystonia 12 2014-05-04 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.